AED Efficacy from Pivotal Trials
Epilepsy/Seizure Drugs in Development
Staccato® alprazolam
Vigadrone (Vigabatrin)
500 mg/packet. ANDA of Aucta Pharmaceuticals LLC marketed by Upsher-Smith Laboratories.
Libervant (DBSF)
Aquestive
- Home
- Search
- Testing Routine Blood Migraine
- Acute Migraine Treatment (status migrainosus), Triptans, NSAIDs
- Behavioral Therapy
- Botox
- Butterbur
- Cannabinoids
- Cerebral Vascular Anatomy
- CGRP Antibodies and Gepants
- Children and Adolescents
- Chronic Pain / Back Pain
- Cluster Headache Treatment
- Contraception - Birth Control
- Depression Screening PHQ-2 and PHQ-9
- Deprescribing/ Withdrawing Medications
- Devices
- Emergency Department Treatment / Steroid Taper
- Epilepsy/Seizure Drugs in Development
- Exercise
- HIT-6 Headache Impact Test
- Headache Tracking
- Headache Types
- Hemiplegic Migraine
- High and Low Pressure Headache
- Hypertension Guidlines
- Indomethacin Responsive Headaches
- IV Infusion Protocols
- Magnesium, Nutritional Supplements and Alternative
- Medication Overuse Headache
- Menopause - Menopausal Vasomotor Symptoms
- Menstruation and Breastfeeding
- Migraine Mimics
- Neck Pain; Spinal Anatomy & Dermtomes
- Nerve Blocks
- Nonpharmacological Measures
- NSAID
- Occipital Epilepsy
- Publications
- Posttraumatic Headache
- Pregnancy
- Preventative Migraine Treatments
- Sleep - Insomnia
- Sphenopalatine Ganglion Block
- Tension Type Headache
- Thunderclap Headache
- Tinnitus
- Triggers/Caffeine
- MIDAS (Migraine Disability Assessment) and ASC-12
- Prodrome and Aura
- SphenoCath
- Vestibular Migraine
- Lawrence Robbins: Advanced Headache Therapy